We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Devicemakers to Shell Out More for Export Certificates

Devicemakers to Shell Out More for Export Certificates

August 21, 2015

Medical devicemakers in the U.S. will have to pay more for their follow-on export certificates. A lot more.

In an Aug. 19 Federal Register notice, the FDA says it is raising the price of subsequent export certificates from $15 to $85 — an increase of about 466 percent.

This marks the first time that costs for these types of certificates, which are issued for the same products as part of the same request, have gone up since 2003.

“These changes are necessary to ensure that the program remains self-sustaining and to cover FDA’s increased costs, which are currently being covered by appropriated funds,” according to the notice. The total cost of the export certification program for devices in FY 2014 was $5.7 million.

As the agency notes, the volume of certificate requests has grown 369 percent since FY 1997, when 11,140 were issued. In FY 2014, 52,193 were issued. Adding to the strain is that devicemakers are permitted to include multiple devices on a single certificate, rather than having to file separate ones.

While the FDA will continue to allow multiple devices to be included on a single certificate, it has cut the maximum number of pages from 50 to 25. That number includes the certificate page and a maximum of 24 more to allow for any attachments. The notice provides additional details on how the agency will determine the total cost of certificates.

Original certificates will continue to cost up to $175. The increased fees for subsequent certificates take effect Sept. 1.

Read the Federal Register notice at www.fdanews.com/082415-export-certificates.pdf. — Elizabeth Hollis

Regulatory Affairs

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • FDA clears text

    Vetex Medical’s Thrombectomy Catheter Cleared by FDA

  • 100Bills_flatmoney.gif

    Merck Purchases Rights to Debiopharm’s Xevinapant for More Than $1 Billion

  • abbott-logo.gif

    Abbott Gets FDA EUA for COVID-19 IgG Antibody Test

  • 100Bills_flatmoney.gif

    In $1.55 Billion Deal, Perrigo Sells Off Generic Drug Business

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing